References
- Ascioglu S, Rex JH, de Pauw W, et al (2002). Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis, 34, 7-14. https://doi.org/10.1086/323335
- Averbuch D, Orasch C, Cordonnier C, et al (2013). European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of emerging resistance: summary of the 4th European conference on infections in leukemia. Haematologica, 98, 1826-35. https://doi.org/10.3324/haematol.2013.091025
- Averbuch D, Cordonnier C, Livermore DM, et al (2013). Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European conference on infections in leukemia (ECIL-4, 2011). Haematologica, 98, 1836-47. https://doi.org/10.3324/haematol.2013.091330
- Clinical and Laboratory Standards Institute (2009). Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement M100-S19. Wayne, PA: Clinical and Laboratory Standards Institute.
- Corrado G, Francesco (2011). Current epidemiology and prevention of infectious complications in cancer patients. Euro Oncol Haematol, 7, 270-7. https://doi.org/10.17925/EOH.2011.07.04.270
- El-Mahallawy HA, Sidhom I, El-Din NH, Zamzam M, El-Lamie MM (2005). Clinical and microbiological determinants of serious blood stream infections in Egyptian pediatric cancer patients : a one year study Int J Infect Dis, 9, 43-51 https://doi.org/10.1016/j.ijid.2003.11.010
- El-Mahallawy HA, El-Wakil M, Moneer MM, Shalaby L (2011). Antibiotic resistance is associated with longer bacteremic episodes and worse outcome in febrile neutropenic children with cancer. Pediatric Blood Cancer, 57, 238-88.
- Giamarellou H (2010). Multidrug-resistant gram-negative bacteria: how to treat and for how long. Int J Antimicrob Agents, 36, 50-4. https://doi.org/10.1016/j.ijantimicag.2010.03.012
- Gudiol C, Bodro M, Simonetti A, et al (2013). Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect, 19, 474-9. https://doi.org/10.1111/j.1469-0691.2012.03879.x
- Hoffmann-Santos HD, Paula CR, Yamamoto AC, Tadano T, Hahn RC (2013).Six-year trend analysis of nosocomial candidemia and risk factors in two intensive care hospitals in Mato Grosso, Midwest Region of Brazil. Mycopathologia, 176, 409-15. https://doi.org/10.1007/s11046-013-9705-5
- Livermore DM, Warner M, Mushtaq S (2011). What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents, 37, 415-9. https://doi.org/10.1016/j.ijantimicag.2011.01.012
- Magiorakos AP, Srinivasan A, Carey RB, et al (2012). Multidrugresistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect, 18, 268-81. https://doi.org/10.1111/j.1469-0691.2011.03570.x
- Mar M, Carlota G, Carol G-V, Carmen A, Jordi C (2014). Bloodstream infections in patients with solid tumors: Epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single center. Medicine, 93, 143-9. https://doi.org/10.1097/MD.0000000000000026
- Naurois J, Novitzky I, Basso, et al (2010). On behalf of the ESMO Guidelines Working Group. Management of febrile neutropenia: ESMO. Clin Practice GuidelinesAnn Oncol, 21, 252-6.
- Paramythiotou, Frantzeska F, Flevari A, Armaganidis A, George DE (2014). Invasive fungal infections in the ICU: how to approach, how to treat. Molecules, 19, 1085-119. https://doi.org/10.3390/molecules19011085
- Rodri guez L, Ethier MC, Phillips B, et al (2012). Utility of peripheral blood cultures in patients with cancer and suspected blood stream infections: A systematic review. Support Care Cancer, 20, 3261-7. https://doi.org/10.1007/s00520-012-1471-2
- Sancho S, Artero A, Zaragoza R, et al (2012). Impact of nosocomial polymicrobial bloodstream infections on the outcome in critically ill patients. Eur J Clin Microbiol Infect Dis, 31, 1791-6. https://doi.org/10.1007/s10096-011-1503-8
- Samonis G, Vardakas KZ, Maraki S, et al (2013). A prospective study of characteristics and outcomes of bacteremia in patients with solid organ or hematologic malignancies. Support Care Cancer, 21, 2521. https://doi.org/10.1007/s00520-013-1816-5
- Trecarichi EM, Tumbarello M, Spanu T, et al (2009). Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J Infect, 58, 299-307. https://doi.org/10.1016/j.jinf.2009.02.002
Cited by
- Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies vol.108, pp.2, 2018, https://doi.org/10.1007/s12185-018-2447-x